Placeholder Banner

BIO's Comment on Advanced Notice of Proposed Rulemaking Regarding Review of Controls for Certain Emerging Technologies

January 17, 2019

BIO urges the Administration to fully assess the potential impact of export controls on biotechnologies on “the impact on the economy of the United States” and on the sustainability of the U.S.’s global leadership in biotechnology, and pursue them “only to the extent necessary” to ensure national security, in accordance with the ECRA statement of policy for export controls in section 4811(1). Before proposing export controls on specific biotechnologies, the Commerce Department should assess the impact of each potential export control on the health of the biotechnology and life sciences ecosystem by evaluating the impact on domestic research, investment into U.S. companies developing or utilizing those technologies, and their ability to recruit and retain skilled talent necessary to develop or deploy those technologies.  

Download Full Comments Below
ANPRM Comments 0
Discover More
The Biotechnology Innovation Organization provided comments to the Treasury Department and Internal Revenue Service on proposed regulations under Section 382 with respect to the built-in gain and built-in loss rules of Section 382(h).
In a recent letter, BIO applauded the Securities and Exchange Commission (SEC) for taking a proactive approach in amending its accelerated and large accelerated filer definitions. “If adopted as proposed, these amendments will benefit startups and…
In a recent letter, BIO’s Jim Greenwood commended Representative Steil (R-WI) for introducing the “Helping Startups Continue to Grow Act,” which extends the exemption afforded to Emerging Growth Companies under the JOBS Act from certain executive…